1. Compatible autoinjection devices must be used for glatiramer acetate

   News item 03 September 2022 Pages: 1 - 1

2. Fake DIPRIVAN in Latin American countries

   News item 03 September 2022 Pages: 2 - 2

3. Hospira recalls one lot of propofol due to particulates

   News item 03 September 2022 Pages: 3 - 3

4. Ibrutinib-related serious arrhythmias and heart failure

   News item 03 September 2022 Pages: 4 - 4

5. Potential risk of vildagliptin-related vasculitis

   News item 03 September 2022 Pages: 5 - 5

6. Restriction of indication for rucaparib due to decreased OS

   News item 03 September 2022 Pages: 6 - 6

7. Adenoviral-based COVID-19 vaccines may increase risk of MI and PE

   Clinical study 03 September 2022 Pages: 7 - 7

8. AstraZeneca, Pfizer-BioNTech, Sinopharm, Sputnik V COVID-19 vaccine

   Clinical study 03 September 2022 Pages: 8 - 8

9. COVID-19 vaccination safe during pregnancy

   Clinical study 03 September 2022 Pages: 9 - 9

10. Immune checkpoint inhibitor-related thromboembolism

    Clinical study 03 September 2022 Pages: 10 - 10

11. Nephrotoxicity of vancomycin increased when combined with piperacillin-tazobactam

    Clinical study 03 September 2022 Pages: 11 - 11

12. No association between patient characteristics and ICI-related SAEs

    Clinical study 03 September 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 03 September 2022 Pages: 13 - 13

14. Abacavir/antidiarrhoeals/nystatin

    Case report 03 September 2022 Pages: 14 - 14

15. Abemaciclib

    Case report 03 September 2022 Pages: 15 - 15

16. Abiraterone/bicalutamide/docetaxel

    Case report 03 September 2022 Pages: 16 - 16

17. Acenocoumarol

    Case report 03 September 2022 Pages: 17 - 17

18. Acenocoumarol

    Case report 03 September 2022 Pages: 18 - 18

19. Acetazolamide

    Case report 03 September 2022 Pages: 19 - 19

20. Acetazolamide/voriconazole

    Case report 03 September 2022 Pages: 20 - 20

21. Acetylcysteine/dipyrone/prednisolone

    Case report 03 September 2022 Pages: 21 - 21

22. Acetylcysteine/paracetamol

    Case report 03 September 2022 Pages: 22 - 22

23. Aciclovir/acetylcysteine/norepinephrine

    Case report 03 September 2022 Pages: 23 - 23

24. Ad26.COV2-S/AZD-1222/immune-globulin

    Case report 03 September 2022 Pages: 24 - 24

25. Ad26.cov2-s/tozinameran

    Case report 03 September 2022 Pages: 25 - 25

26. Adalimumab

    Case report 03 September 2022 Pages: 26 - 26

27. Adalimumab

    Case report 03 September 2022 Pages: 27 - 27

28. Adalimumab/methotrexate/prednisone

    Case report 03 September 2022 Pages: 28 - 28

29. Adalimumab/secukinumab

    Case report 03 September 2022 Pages: 29 - 29

30. Aflibercept/ranibizumab/spironolactone

    Case report 03 September 2022 Pages: 30 - 30

31. Alcohol

    Case report 03 September 2022 Pages: 31 - 31

32. Alectinib/carboplatin/etoposide

    Case report 03 September 2022 Pages: 32 - 32

33. Alemtuzumab/prednisolone

    Case report 03 September 2022 Pages: 33 - 33

34. Alpha-hydroxy-gamma-methylmercaptobutyric-acid/alpha-ketoisocaproic-acid/alpha-ketoisovalerate/calcium/histidine/lysine-hydrochloride/nitrogen/phenylpyruvic-acid/threonine/tryptophan/tyrosine

    Case report 03 September 2022 Pages: 34 - 34

35. Alprazolam

    Case report 03 September 2022 Pages: 35 - 35

36. Amfetamine

    Case report 03 September 2022 Pages: 36 - 36

37. Amikacin/ceftazidime/ciprofloxacin

    Case report 03 September 2022 Pages: 37 - 37

38. Aminolevulinic-acid/erlotinib

    Case report 03 September 2022 Pages: 38 - 38

39. Amiodarone

    Case report 03 September 2022 Pages: 39 - 39

40. Amiodarone

    Case report 03 September 2022 Pages: 40 - 40

41. Amiodarone

    Case report 03 September 2022 Pages: 41 - 41

42. Amiodarone/paracetamol

    Case report 03 September 2022 Pages: 42 - 42

43. Amitriptyline/antihistaminics/corticosteroids

    Case report 03 September 2022 Pages: 43 - 43

44. Amivantamab

    Case report 03 September 2022 Pages: 44 - 44

45. Amlodipine

    Case report 03 September 2022 Pages: 45 - 45

46. Amlodipine

    Case report 03 September 2022 Pages: 46 - 46

47. Amoxicillin

    Case report 03 September 2022 Pages: 47 - 47

48. Amoxicillin/clavulanic acid

    Case report 03 September 2022 Pages: 48 - 48

49. Amoxicillin/clavulanic acid/metronidazole

    Case report 03 September 2022 Pages: 49 - 49

50. Amoxicillin/clavulanic-acid/dapsone/nevirapine

    Case report 03 September 2022 Pages: 50 - 50